These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34772528)

  • 1. Identification of (6S)-cyclopropyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxamines as new HBV capsid assembly modulators.
    Lv K; Wu S; Tao Z; Wang A; Xu S; Yang L; Gao Q; Wang A; Qin X; Jiang B; Wu W; Jia X; Li Y; Jiang J; Liu M
    Eur J Med Chem; 2022 Jan; 228():113974. PubMed ID: 34772528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
    Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new class of HBV capsid assembly modulator.
    Kuduk SD; Stoops B; Alexander R; Lam AM; Espiritu C; Vogel R; Lau V; Klumpp K; Flores OA; Hartman GD
    Bioorg Med Chem Lett; 2021 May; 39():127848. PubMed ID: 33610748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxadiazepinone HBV capsid assembly modulators.
    Kuduk SD; Stoops B; Lam AM; Espiritu C; Vogel R; Lau V; Klumpp K; Flores OA; Hartman GD
    Bioorg Med Chem Lett; 2021 Nov; 52():128353. PubMed ID: 34492302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulators.
    Kuduk SD; Lam AM; Espiritu C; Vogel R; Lau V; Klumpp K; Flores OA; Hartman GD
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2405-2409. PubMed ID: 31227344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays.
    Wang Y; Wang Z; Liu J; Wang Y; Wu R; Sheng R; Hou T
    Bioorg Med Chem; 2021 Apr; 36():116096. PubMed ID: 33721800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
    Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators.
    Liang M; Liu L; Liu J; Yang Z; Wang M; Xie Y; Cai Y; Xue P; Chen Y; Zhan P; Jia H
    Bioorg Med Chem Lett; 2024 Nov; 112():129913. PubMed ID: 39111727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors.
    Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H
    Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Oxooctahydroquinoline-1(2H)-carboxamides as hepatitis B virus (HBV) capsid core protein assembly modulators.
    Hwang N; Ban H; Wu S; McGuire K; Hernandez E; Chen J; Zhao Q; Suresh M; Blass B; Viswanathan U; Kulp J; Chang J; Clement J; Menne S; Guo JT; Du Y
    Bioorg Med Chem Lett; 2022 Feb; 58():128518. PubMed ID: 34979256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors.
    Ma Y; Zhao S; Ren Y; Cherukupalli S; Li Q; Woodson ME; Bradley DP; Tavis JE; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 225():113780. PubMed ID: 34438123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators.
    Wang S; Ren Y; Li Q; Wang Y; Jiang X; Xu S; Zhang X; Zhao S; Bradley DP; Woodson ME; Zhao F; Wu S; Li Y; Tian Y; Liu X; Tavis JE; Zhan P
    Bioorg Chem; 2022 Dec; 129():106192. PubMed ID: 36265355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
    Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
    Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.
    Senaweera S; Du H; Zhang H; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Discovery of
    Yang Y; Yan Y; Yin J; Hu J; Cai X; Hu J; Xia J; Wang K; Tang N; Huang L
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy.
    Kim H; Ko C; Lee JY; Kim M
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector.
    Sari O; Boucle S; Cox BD; Ozturk T; Russell OO; Bassit L; Amblard F; Schinazi RF
    Eur J Med Chem; 2017 Sep; 138():407-421. PubMed ID: 28688280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of benzimidazole-based compounds as novel capsid assembly modulators for the treatment of HBV infection.
    Du K; Wang X; Bai Y; Zhang X; Xue J; Li S; Xie Y; Sang Z; Tang Y; Wang X
    Eur J Med Chem; 2024 May; 271():116402. PubMed ID: 38636128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Design, Synthesis, and Structure-Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836.
    Cole AG; Kultgen SG; Mani N; Fan KY; Ardzinski A; Stever K; Dorsey BD; Mesaros EF; Thi EP; Graves I; Tang S; Harasym TO; Lee ACH; Olland A; Suto RK; Sofia MJ
    J Med Chem; 2024 Sep; 67(18):16773-16795. PubMed ID: 39231272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors.
    Boucle S; Lu X; Bassit L; Ozturk T; Russell OO; Amblard F; Coats SJ; Schinazi RF
    Bioorg Med Chem Lett; 2017 Feb; 27(4):904-910. PubMed ID: 28094179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.